GW PHARMACEUTICALS
GW is a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics from its proprietary cannabinoid product platform in a broad range of disease areas. The Company's lead product, EPIDIOLEX (cannabidiol) oral solution, is commercialized in the U.S. by its U.S. subsidiary Greenwich Biosciences for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome, or tuberous sclerosis complex (TSC) in patients one year of age and ol... der. This product has received approval in the European Union under the tradename EPIDYOLEX for the adjunctive treatment of seizures associated with LGS or Dravet syndrome in conjunction with clobazam in patients two years and older and is under EMA review for the treatment of TSC. The Company has a deep pipeline of additional cannabinoid product candidates, in particular nabiximols, for which the Company is advancing multiple late-stage clinical programs in order to seek FDA approval in the treatment of spasticity associated with multiple sclerosis and spinal cord injury. The Company has additional cannabinoid product candidates in clinical trials for autism and schizophrenia.
GW PHARMACEUTICALS
Social Links:
Industry:
Biotechnology Cannabis Health Care Pharmaceutical Therapeutics
Founded:
1998-01-01
Address:
Histon, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.gwpharm.com
Total Employee:
501+
Status:
Active
Contact:
+44 (0) 1223 238170
Email Addresses:
[email protected]
Total Funding:
1.22 B USD
Technology used in webpage:
SPF LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Domain Not Resolving Euro Microsoft Exchange Online Amazon IPv6 JsDelivr
Similar Organizations
2A Pharma
2A Pharma is a biopharmaceutical company focused on discovering, developing and commercialising novel, cost effective vaccines.
CANbridge Pharmaceuticals
CANbridge Pharmaceuticals is a bio-pharmaceutical company accelerating development and commercialization of specialty healthcare .
CannAssist International
CannAssist International is a researched-based company focused on creating higher-level alternative therapeutics.
Crinetics Pharmaceuticals
Crinetics is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics.
Kalapa Clinic
Kalapa Clinic is a medical consultancy pioneered for alternative therapies using cannabinoids.
Keros Therapeutics
Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.
Scilex Pharmaceuticals
Scilex Pharmaceuticals is an emerging pharmaceutical company focused on acquiring and commercializing late-stage prescription products.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Mentor Capital
Mentor Capital investment in Post-IPO Equity - GW Pharmaceuticals
Official Site Inspections
http://www.gwpharm.com
- Host name: ec2-52-88-89-3.us-west-2.compute.amazonaws.com
- IP address: 52.88.89.3
- Location: Boardman United States
- Latitude: 45.8491
- Longitude: -119.7143
- Metro Code: 810
- Timezone: America/Los_Angeles
- Postal: 97818
More informations about "GW Pharmaceuticals" on Search Engine
GW Pharmaceuticals - Wikipedia
GW Pharmaceuticals Limited is a British pharmaceutics company known for its multiple sclerosis treatment product nabiximols (brand name, Sativex) which was the first natural cannabis plant derivative to gain market approval in any country. Another cannabis-based product, Epidiolex, was approved for treatment of epilepsy by the US Food and Drug Administration in 2018. It is a subsidiary of Jazz PharmaceuticalsSee details»
Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, …
DUBLIN and LONDON, Feb. 3, 2021 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) and GW Pharmaceuticals plc (Nasdaq: GWPH) today announced the companies …See details»
GW Pharmaceuticals - Crunchbase Company Profile & Funding
GW Pharmaceuticals is a biopharmaceutical company focused on discovering, developing, and commercializing novel therapeutics. Acquired by. Jazz Pharmaceuticals. Histon, …See details»
Jazz agrees $7.2bn deal for British cannabis pioneer GW …
Feb 3, 2021 Jazz Pharmaceuticals has agreed to buy GW Pharmaceuticals, a British pioneer in cannabis-based medicines, in a $7.2bn cash-and-stock deal that will expand …See details»
GW Pharmaceuticals Shareholders Approve Acquisition by Jazz …
LONDON and DUBLIN, April 23, 2021 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH) (GW) and Jazz Pharmaceuticals plc (Nasdaq: JAZZ) (Jazz) today …See details»
GW Pharmaceuticals Shareholders Approve Acquisition by Jazz ...
April 23, 2021. Download PDF. LONDON and DUBLIN, April 23, 2021 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH) (GW) and Jazz …See details»
GW Pharmaceuticals plc Reports Fourth Quarter and Year-End …
Feb 16, 2021 LONDON and CARLSBAD, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH), a world leader in the science, development, …See details»
Transforming Together: What Our Recent ... - Jazz Pharmaceuticals
Today is an exciting and transformative day for Jazz Pharmaceuticals as we complete the acquisition of GW Pharmaceuticals and its U.S. subsidiary, Greenwich Biosciences, a …See details»
Jazz Pharmaceuticals Completes Acquisition of GW …
DUBLIN, May 5, 2021 /PRNewswire/ -- Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced the completion of its acquisition of GW Pharmaceuticals plc (Nasdaq: …See details»
GW Pharma Soars To Record High On Jazz's $7.2 Billion …
Feb 3, 2021 ALLISON GATLIN. 04:25 PM ET 02/03/2021. Jazz Pharmaceuticals ( JAZZ) agreed to buy GW Pharmaceuticals ( GWPH) for $7.2 billion on Wednesday — sending …See details»
Jazz To Acquire Cannabinoid Drug Company GW Pharma For …
Feb 3, 2021 JAZZ. In the first big-ticket biopharma M&A of the year, Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) announced a deal to buy cannabinoid drug …See details»
GW Pharmaceuticals receives approval for EPIDYOLEX® …
LONDON, Aug. 10, 2021 /PRNewswire/ -- GW Pharmaceuticals ("GW"), a world leader in discovering, developing and delivering regulatory approved cannabis-based medicines …See details»
GW Cannabinoid Platform | Jazz Pharmaceuticals
Over more than two decades, GW Pharmaceuticals, now a part of Jazz Pharmaceuticals, established a world-leading cannabinoid science platform to develop a deep, innovative …See details»
Jazz Pharmaceuticals Completes Acquisition of GW ... - Nasdaq
DUBLIN, May 5, 2021 /PRNewswire/ -- Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced the completion of its acquisition of GW Pharmaceuticals plc (Nasdaq: …See details»
Jazz to Acquire GW Pharmaceuticals
Feb 3, 2021 Leading cannabinoid platform and unique expertise . significantly expand Jazz’s. acquired or launched since 2019 neuroscience pipeline. expected to contribute …See details»
GW Pharmaceuticals Annual Report 2021 - StockLight
EXPLANATORY NOTE. GW Pharmaceuticals plc (the “Company” or “we” or “us” or “GW”) is filing this Amendment No. 1 on Form 10-K/A (this “Amendment”) to amend our Annual …See details»
gwph-10k_20201231.htm - SEC.gov
Dec 31, 2020 PART I. GENERAL INFORMATION. In this Annual Report, “GW Pharma,” the “Group,” the “Company,” “we,” “us” and “our” refer to GW Pharmaceuticals plc and …See details»
GW Pharmaceuticals Shareholders Approve Acquisition by Jazz …
Published. Apr 23, 2021 4:01pm EDT. LONDON and DUBLIN, April 23, 2021 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq: GWPH) (GW) and Jazz …See details»
GW Pharmaceuticals - Funding, Financials, Valuation & Investors
GW Pharmaceuticals has raised a total of. $1.2B. in funding over 6 rounds. Their latest funding was raised on Oct 2, 2018 from a Post-IPO Equity round. GW Pharmaceuticals …See details»
Jazz Pharmaceuticals Completes Acquisition of GW ... - BioSpace
DUBLIN, May 5, 2021 /PRNewswire/ -- Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced the completion of its acquisition of GW Pharmaceuticals plc (Nasdaq: …See details»